MUFG) and Nomura Securities International announced a $388m financing package for Greenalia's Misae Solar Park II (Misae II) ...

Vistra's robust hedging book, improved credit profile, and clean energy exposure support a higher EV/EBITDA multiple. See why ...

EMAS Pharma has rebranded as Evestia Clinical as it sets its sights on rapid growth as a provider of clinical research in oncology and rare diseases.